Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today ...

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery ...

Several rare disease patient populations received their first-ever FDA-approved drug since Rare Disease Day last year, ...

ITF, IntraBio and Orchard are among the companies that have won FDA nods in the past year for Duchenne muscular dystrophy, ...

BOSTON (AP) — BOSTON (AP) — Verve Therapeutics Inc. (VERV) on Thursday reported a loss of $50 million in its fourth quarter. The Boston-based company said it had a loss of 58 cents per share.

Heron Therapeutics (NASDAQ:HRTX) (market cap: $260 million) reported a profitable fourth quarter for 2024, surpassing earnings expectations with an EPS of $0.02 against a forecast of -$0.03.

Try Now>> See today’s best-performing stocks on TipRanks >> Read More on TNGX: Tango Therapeutics NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

Douglas Ingram; President, Chief Executive Officer, Director; Sarepta Therapeutics Inc Dallan Murray; Executive Vice President, Chief Customer Officer; Sarepta Therapeutics Inc Louise Rodino-Klapac; ...

Feb. 27, 2025 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today reported ...